Price data is not available
MINDBIO THERAPEUTICS CORP by MindBio Therapeutics Corp.
MBQIFOTCQB
MINDBIO THERAPEUTICS CORP by MindBio Therapeutics fell 93.0% from $0.79 to $0.06, behind the S&P 500's +10.9%. Its worst day was Jan 29 (−71.0%), and its low came Oct 1 at $0.05.
Jan 21, 2026 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
MINDBIO THERAPEUTICS CORP by MindBio Therapeutics closed at its highest level of the year, 70.9% above where the year started.
+21.6% · S&P 500 +0.5%
MINDBIO THERAPEUTICS CORP by MindBio Therapeutics shares rose 88.1%, while the S&P 500 fell 0.5%.
Story events cover the past 12 months · Times ET
+88.1% · S&P 500 −0.5%
Where it ended: a close of $0.06 on Nov 9, 2026.
Nothing in the past 12 months.
All MBQIF earningsNothing in the past 12 months.
All MBQIF analyst actionsNothing in the past 12 months.
All MBQIF dividend historyNothing in the past 12 months.
All MBQIF news
